CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $3,277,000 | +16.2% | 259,245 | -9.7% | 0.01% | +20.0% |
Q3 2020 | $2,820,000 | -7.9% | 287,195 | -6.6% | 0.01% | -16.7% |
Q2 2020 | $3,061,000 | +6.5% | 307,632 | -5.4% | 0.01% | 0.0% |
Q1 2020 | $2,875,000 | -15.3% | 325,193 | -11.6% | 0.01% | +20.0% |
Q4 2019 | $3,393,000 | +51.5% | 367,793 | -3.5% | 0.01% | +25.0% |
Q3 2019 | $2,239,000 | -47.0% | 380,949 | +8.1% | 0.00% | -42.9% |
Q2 2019 | $4,228,000 | +167.8% | 352,338 | +169.3% | 0.01% | +133.3% |
Q1 2019 | $1,579,000 | +54.2% | 130,826 | +60.3% | 0.00% | +50.0% |
Q4 2018 | $1,024,000 | -13.8% | 81,616 | +2.0% | 0.00% | 0.0% |
Q3 2018 | $1,188,000 | -14.8% | 80,006 | -3.4% | 0.00% | 0.0% |
Q2 2018 | $1,395,000 | -17.6% | 82,862 | +12.1% | 0.00% | -33.3% |
Q1 2018 | $1,693,000 | +27.3% | 73,904 | +43.7% | 0.00% | +50.0% |
Q4 2017 | $1,330,000 | +38.8% | 51,443 | -20.7% | 0.00% | +100.0% |
Q3 2017 | $958,000 | -30.4% | 64,910 | -34.2% | 0.00% | -50.0% |
Q2 2017 | $1,376,000 | -68.1% | 98,630 | -61.0% | 0.00% | -71.4% |
Q1 2017 | $4,319,000 | +109.2% | 253,130 | +26.2% | 0.01% | +133.3% |
Q4 2016 | $2,065,000 | -2.0% | 200,630 | -3.8% | 0.00% | 0.0% |
Q3 2016 | $2,108,000 | -18.7% | 208,530 | -9.7% | 0.00% | -25.0% |
Q2 2016 | $2,594,000 | -21.5% | 230,990 | -4.5% | 0.00% | -33.3% |
Q1 2016 | $3,303,000 | -19.8% | 241,790 | +11.4% | 0.01% | -14.3% |
Q4 2015 | $4,118,000 | +136.1% | 217,100 | +133.7% | 0.01% | +133.3% |
Q3 2015 | $1,744,000 | – | 92,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 968,198 | $9,634,000 | 3.29% |
INGALLS & SNYDER LLC | 1,382,048 | $13,751,000 | 0.79% |
SPHERA FUNDS MANAGEMENT LTD. | 700,710 | $6,972,000 | 0.66% |
Alambic Investment Management, L.P. | 17,900 | $178,000 | 0.45% |
RA Capital Management | 1,858,474 | $18,492,000 | 0.36% |
Perceptive Advisors | 2,150,641 | $21,398,000 | 0.35% |
Eversept Partners, LP | 232,983 | $2,318,181 | 0.32% |
GSA CAPITAL PARTNERS LLP | 17,351 | $173,000 | 0.10% |
Alyeska Investment Group, L.P. | 502,783 | $5,003,000 | 0.08% |
KENNEDY CAPITAL MANAGEMENT LLC | 263,958 | $2,626,000 | 0.08% |